Friday, December 1st, 2017 /
Comments Off on Amgen gets FDA OK to market Repatha’s ability to prevent heart attacks
NEXT ARTICLE →Revenues down at Stellar Biotechnologies
← PREVIOUS ARTICLEAmgen partners with Biocartis on diagnostic tests for cancer drug
View all articles by Staff Report »
You might also like...